Infliximab induces disease remission in patients with rheumatoid arthritis: Results from START clinical trial

被引:0
|
作者
Yocum, D
Rahman, MU
Han, CL
Bala, M
Han, J
Westhovens, R
机构
[1] Univ Arizona, Tucson, AZ USA
[2] Centocor Inc, Horsham, PA USA
[3] Univ Hosp Gasthuisberg, Dept Rheumatol, Louvain, Belgium
来源
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S140 / S140
页数:1
相关论文
共 50 条
  • [41] ACPA and RF As Predictors of Sustained Clinical Remission in Rheumatoid Arthritis Patients: Data from a Rheumatoid Arthritis Cohort
    Pope, Janet E.
    Rampakakis, Emmanouil
    Movahedi, Mohammad
    Cesta, Angela
    Sampalis, John S.
    Bombardier, Claire
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [42] ACPA and RF as Predictors of Sustained Clinical Remission in Rheumatoid Arthritis Patients: Data from a Rheumatoid Arthritis Cohort
    Pope, Janet
    Movahedi, Mohammad
    Rampakakis, Emmanouil
    Cesta, Angela
    Sampalis, John
    Bombardier, Claire
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1003 - 1004
  • [43] Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission
    Hurnakova, Jana
    Hulejova, Hana
    Zavada, Jakub
    Komarc, Martin
    Hanova, Petra
    Klein, Martin
    Mann, Herman
    Sleglova, Olga
    Olejarova, Marta
    Forejtova, Sarka
    Ruzickova, Olga
    Vencovsky, Jiri
    Pavelka, Karel
    Senolt, Ladislav
    PLOS ONE, 2016, 11 (11):
  • [44] Adalimumab induces and maintains clinical response and remission in patients with active Crohn's disease: Results of the CHARM Trial
    Colombel, J.
    Sandborn, W. J.
    Rutgeerts, P.
    Enns, R.
    Hanauer, S. B.
    Remo, P.
    Schreiber, S.
    Lomax, K. G.
    Pollack, P. F.
    GASTROENTEROLOGY, 2006, 131 (03) : 950 - 950
  • [45] Similar levels of disease activity and remission rates in patients with psoriatic arthritis and rheumatoid arthritis—results from the Finnish quality register
    Lauri Weman
    Henri Salo
    Laura Kuusalo
    Johanna Huhtakangas
    Johanna Kärki
    Paula Vähäsalo
    Maria Backström
    Tuulikki Sokka-Isler
    Clinical Rheumatology, 2024, 43 : 633 - 643
  • [46] Immunization Responses in Rheumatoid Arthritis Patients Treated With Rituximab Results From a Controlled Clinical Trial
    Bingham, Clifton O., III
    Looney, R. John
    Deodhar, Atul
    Halsey, Neal
    Greenwald, Maria
    Codding, Christine
    Trzaskoma, Benjamin
    Martin, Flavius
    Agarwal, Sunil
    Kelman, Ariella
    ARTHRITIS AND RHEUMATISM, 2010, 62 (01): : 64 - 74
  • [47] CLINICAL CHARACTERISTICS OF RHEUMATOID ARTHRITIS PATIENTS TO BE INTENSIFIED INFLIXIMAB THERAPY
    Oguma, A.
    Irino, K.
    Sawabe, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 946 - 946
  • [48] SONOGRAPHIC AND CLINICAL CHARACTERIZATION OF A PROSPECTIVE COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL REMISSION. PRELIMINARY RESULTS
    Ramirez Garcia, J.
    Ruiz-Esquide, V.
    Celis, R.
    Cuervo, A.
    Cabrera, S.
    Inciarte-Mundo, J.
    Sanmarti, R.
    Canete, J. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 888 - 888
  • [49] Is remission achievable in most patients with rheumatoid arthritis? Results suggest not
    Bukhari, Marwan
    RHEUMATOLOGY, 2019, 58 (02) : 187 - 188
  • [50] Persistence in Low Disease Activity or Remission with Etanercept Monotherapy in Patients with Rheumatoid Arthritis: Results from the Corrona Registry
    Pappas, Dimitrios A.
    Shan, Ying
    Lesperance, Tamara
    Rebello, Sabrina
    Karis, Elaine
    Kricorian, Greg
    Hua, Winnie
    Accortt, Neil A.
    Stryker, Scott
    ARTHRITIS & RHEUMATOLOGY, 2018, 70